Evidence map›Paper›PMID 34554877›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2021

Interactions Between Dose and Volume in Chemoradiotherapy of Esophageal Cancer.

Christoph Pöttgen, Ursula Nestle, Stefan Höcht, Martin Stuschke

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Christoph PöttgenChristoph Pöttgen, MD, PhD, Department of Radiation Oncology, West German Cancer Center, Medical Faculty, University Hospital Essen, Essen, Germany; Ursula Nestle, MD, PhD, Department of Radiation Oncology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany, Department of Radiation Oncology, Kliniken Maria Hilf, Möchengladbach, Germany; Stefan Höcht, MD, PhD, Department of Radiotherapy, Xcare Group Practices, Saarlouis, Germany; and Martin Stuschke, MD, PhD, Department of Radiation Oncology, West German Cancer Center, Medical Faculty, University Hospital Essen, Essen, Germany.ORCID 0000-0002-9224-9318
Ursula NestleChristoph Pöttgen, MD, PhD, Department of Radiation Oncology, West German Cancer Center, Medical Faculty, University Hospital Essen, Essen, Germany; Ursula Nestle, MD, PhD, Department of Radiation Oncology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany, Department of Radiation Oncology, Kliniken Maria Hilf, Möchengladbach, Germany; Stefan Höcht, MD, PhD, Department of Radiotherapy, Xcare Group Practices, Saarlouis, Germany; and Martin Stuschke, MD, PhD, Department of Radiation Oncology, West German Cancer Center, Medical Faculty, University Hospital Essen, Essen, Germany.
Stefan HöchtChristoph Pöttgen, MD, PhD, Department of Radiation Oncology, West German Cancer Center, Medical Faculty, University Hospital Essen, Essen, Germany; Ursula Nestle, MD, PhD, Department of Radiation Oncology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany, Department of Radiation Oncology, Kliniken Maria Hilf, Möchengladbach, Germany; Stefan Höcht, MD, PhD, Department of Radiotherapy, Xcare Group Practices, Saarlouis, Germany; and Martin Stuschke, MD, PhD, Department of Radiation Oncology, West German Cancer Center, Medical Faculty, University Hospital Essen, Essen, Germany.ORCID 0000-0001-6021-5984
Martin StuschkeChristoph Pöttgen, MD, PhD, Department of Radiation Oncology, West German Cancer Center, Medical Faculty, University Hospital Essen, Essen, Germany; Ursula Nestle, MD, PhD, Department of Radiation Oncology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany, Department of Radiation Oncology, Kliniken Maria Hilf, Möchengladbach, Germany; Stefan Höcht, MD, PhD, Department of Radiotherapy, Xcare Group Practices, Saarlouis, Germany; and Martin Stuschke, MD, PhD, Department of Radiation Oncology, West German Cancer Center, Medical Faculty, University Hospital Essen, Essen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ChemoradiotherapyEsophageal NeoplasmsHumans

Identifiers

PMID34554877

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.